Inspire Medical Systems, Inc. (“Inspire”) announced today that Cigna, one of the leading health plans in the United States, will provide coverage for the Company’s Inspire therapy (hypoglossal nerve neurostimulation), effective June 15, 2020. Cigna Corporation is a global health service company that provides health insurance coverage for approximately 16 […]
ARTICLES
Empowering Handbook Offers Simple Steps To Help Us Respond Positively When Facing Life’s Challenges
With all the negativity we’ve had to deal with in our nation this year, it’s no wonder we’re feeling anxious and afraid. We need to find a simple way to overcome these disturbing emotions, so we can better face the challenges in life and find a path to peace and […]
Live Webinar: Precision Medicine for OSA and Emerging Technologies
Nuvaira Dnerva Wins FDA Breakthrough Designation for COPD Treatment
Minneapolis-based startup Nuvaira Inc. has received breakthrough device designation from the U.S. FDA for its Dnerva lung denervation system to reduce the risk of moderate-to-severe exacerbations of chronic obstructive pulmonary disease (COPD) in patients receiving optimal care. The bronchoscopic procedure works by disrupting pulmonary nerve input to the lung, improving symptoms and […]
🍍EnsoData Raises $9 Million to Broaden Sleep Artificial Intelligence
EnsoData, the company simplifying the process for analyzing the human body to accurately diagnose health conditions, has announced $9 million Series A financing led by Venture Investors and Zetta Venture Partners. Using artificial intelligence, EnsoData’s technology transforms billions of waveform data points collected from sensors in medical devices and wearables into […]
The RPSGT Exam – Troubleshooting Tricky Areas
By: Rachel Mouton, RPSGT, CCSH, LPN, Chair of the Exam Development Committee and Becky Appenzeller, RPSGT, R. EEG T., CNIM, CCSH, Director of the Exam Development Committee In an effort to further support our exam candidates, we conducted a lengthy review of RPSGT exam results going back as far as […]
Nation Must Prepare for COVID-19 Related Drug Shortages
A new paper published online in the Annals of the American Thoracic Society examines the nation’s current shortage of vitally needed medications, and how this dangerous situation is being made worse by the COVID-19 pandemic. The authors provide recommendations on how clinicians and institutions might address potential scarcities of essential medications during the current […]
CMS Update Makes VOCSN Accessible to All Vent Users
Permanent Update to Multi-Function Ventilator Code Increases Access to Integrated Respiratory Care for All Ventilator Users On May 29, 2020, the Centers for Medicare and Medicaid Services (CMS) updated its policy for HCPCS code E0467 (Multi-Function Ventilator) removing “same or similar” restrictions and paving the way for increased access to integrated […]
ATS Responds to the Death of George Floyd and Subsequent Events
On June 1, 2020, the American Thoracic Society issued the following statement regarding the death of George Floyd: The recent tragic death of Mr. George Floyd in Minneapolis and subsequent protests throughout the United States and in cities around the world call on us to again examine the role of […]
CAIRE Acquires Spirosure Fractional Exhaled Nitric Oxide (FeNO) Device
CAIRE Inc. has announced the acquisition of Spirosure, Inc. Spirosure is a California-based developer and manufacturer of innovative technology for measuring Fractional Exhaled Nitric Oxide (FeNO), a key indicator of allergic inflammation in asthmatic patients. It is estimated that asthma affects more than 300 million individuals worldwide and recent Global […]













